|
|
|
(State or other jurisdiction
|
(Commission
|
(I.R.S. Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered |
N|A
|
N|A
|
N|A
|
ARCH THERAPEUTICS, INC.
|
||
Dated: December 8, 2023
|
By:
|
/s/ Terrence W. Norchi, M.D.
|
Name: Terrence W. Norchi, M.D.
Title: President, Chief Executive Officer
|
Document And Entity Information |
Dec. 05, 2023 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | ARCH THERAPEUTICS, INC. |
Document, Type | 8-K |
Document, Period End Date | Dec. 05, 2023 |
Entity, Incorporation, State or Country Code | NV |
Entity, File Number | 000-54986 |
Entity, Tax Identification Number | 46-0524102 |
Entity, Address, Address Line One | 235 Walnut Street, Suite 6 |
Entity, Address, City or Town | Framingham |
Entity, Address, State or Province | MA |
Entity, Address, Postal Zip Code | 01702 |
City Area Code | 617 |
Local Phone Number | 431-2313 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0001537561 |
&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !$ MA(A799!YDAD! #/ P $P @ %+$@ 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 "0 ) #X" "5$P ! end